CA41892-7 - 0x000000000000616B
Healthy Males & Females
Alloy
* Stipend may pay up to reflected amount.
Start Date:
October 18, 2024 - 12:30pm
End Date:
October 26, 2024 - 7:15am
Study Details
Study Number: CA41892
Group Number: 7
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,500.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat multiple sclerosis.
Route of Administration: Oral
Blood Draws: 20
Study Schedule
Schedule Type: Short stays with returns
Study Length: 4 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 10/17/2024 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 10/17/2024 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Friday | 10/18/2024 12:30:00 PM | Tuesday | 10/22/2024 7:15:00 AM | 1 | Lincoln |
| Return | Saturday | 10/26/2024 5:45:00 AM | Saturday | 10/26/2024 7:15:00 AM | 1 | Lincoln |
